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LETTERS
 Rhabdomyolysis 
and Pandemic 
(H1N1) 2009 
Pneumonia in Adult
To the Editor: A 56-year-old 
man came to the emergency depart-
ment (ED) of Malcolm Grow Medical 
Center at Andrews Air Force Base in 
suburban Maryland, USA, just outside 
Washington, DC. He had a history 
of several days of cough, fever, and 
malaise; was a nonsmoker; was over-
weight (body mass index 28 kg/m2); 
and did not have chronic pulmonary 
disease. Radiographs showed bilateral 
pulmonary inﬁ  ltrates, and he was hy-
poxemic. Two weeks previously, the 
patient had begun receiving therapy 
for recurrent multiple myeloma (le-
nalidomide and high-dose dexametha-
sone). He was intubated at the time 
of initial visit to the ED for inﬂ  uenza 
symptoms, and broad-spectrum an-
timicrobial drugs were administered 
(vancomycin 1,000 mg every 12 h, 
piperacillin-tazobactam 4.5 gm every 
6 h, and levoﬂ  oxacin 750 mg 1×/d). 
Initial nasopharyngeal wash was neg-
ative for inﬂ  uenza A and B antigen by 
enzyme immunoassay; serum creatine 
kinase was 271 U/L (reference range 
38–174 U/L). 
After oxygenation worsened, 
bronchoalveolar lavage was per-
formed, and drug therapy was 
broadened to include voriconazole, 
trimethoprim-sulfamethoxazole, and 
prednisone. Bronchoalveolar lavage 
viral culture was positive for inﬂ  uenza 
A, and real-time reverse transcription–
PCR conﬁ   rmed pandemic (H1N1) 
2009 virus infection. Therapy with 
oseltamivir (75 mg every 12 h) was 
initiated, and the patient’s respiratory 
status gradually improved. On hospi-
tal day 14, total creatine kinase levels 
were elevated at 4,854 U/L and rose 
to 76,015 U/L over the next 4 days 
before decreasing. Urine myoglobin 
peaked at 286,000 μg/L (reference 
range 0–28 μg/L). Renal function re-
mained at baseline until the patient 
was discharged 2 weeks later; mea-
sured glomerular ﬁ  ltration rates were 
>120 mL/min. Hydration with normal 
saline and supportive care was pro-
vided; the patient was extubated and 
discharged to a rehabilitation hospital 
on hospital day 19. No medications or 
other treatments could be implicated 
as the cause of rhabdomyolysis in this 
patient.
More commonly reported in chil-
dren, myositis associated with inﬂ  uen-
za A and B has been well documented 
and appears to occur most often during 
the convalescent phase of illness (1). 
Inﬂ  uenza-associated  rhabdomyolysis 
with myoglobinuria have been shown 
to complicate 3% of cases of myositis 
in children, are more likely to be asso-
ciated with inﬂ  uenza A infection (1), 
and have been associated with renal 
insufﬁ  ciency requiring renal replace-
ment therapy (1,2). The frequency of 
myositis or rhabdomyolysis among 
adults with pandemic (H1N1) 2009 
infection is unclear, but a recently 
published case series of 18 severely ill 
patients in Mexico showed that mild 
to moderate creatine kinase elevation 
(1,000–5,000 U/L) occurred in >60% 
of tested patients (3). A report from 
Australia documented rhabdomy-
olysis as a complication of pandemic 
(H1N1) 2009 infection in a 16-year-
old-boy (4), and, more recently, a case 
of rhabdomyolysis was reported in a 
28-year-old patient (5). 
Our case demonstrates rhab-
domyolysis with myoglobinuria that 
arose during convalescence from se-
vere pandemic (H1N1) 2009 pneumo-
nia in an immunocompromised adult. 
It is yet to be determined whether 
pandemic (H1N1) 2009 virus infec-
tion has a higher propensity toward 
muscular inﬂ  ammation than do other 
viral infections or seasonal inﬂ  uenza. 
Rhabdomyolysis should be considered 
in the evaluation of muscle symptoms 
associated with pandemic (H1N1) 
2009 virus infection, especially 
among critically ill patients. When 
inﬂ  uenza suspicion is high, obtaining 
bronchoalveolar lavage specimens for 
viral culture, PCR, and antigen testing 
should be considered if nasopharynge-
al sampling and testing for inﬂ  uenza 
antigen and viral culture are initially 
negative. 
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